benzoyl peroxide has been researched along with clindamycin phosphate in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (16.00) | 18.7374 |
| 1990's | 2 (8.00) | 18.2507 |
| 2000's | 6 (24.00) | 29.6817 |
| 2010's | 11 (44.00) | 24.3611 |
| 2020's | 2 (8.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rajka, G | 1 |
| Fanta, D; Neumann, R; Raab, W; Schmidt, JB | 1 |
| Baker, MD; Mills, OH; Swinyer, LJ; Swinyer, TA | 1 |
| Cochran, R; Flannigan, SA; Tausend, R; Tucker, SB | 1 |
| Brown, RH; Dunlap, FE; Kraus, SJ; Packman, AM; Webster, GF | 1 |
| Caron, D; Clucas, A; Sorba, V; Verschoore, M | 1 |
| Tan, JK | 1 |
| Finlay, AY; Kellett, N; West, F | 1 |
| Del Rosso, JQ; Tanghetti, E | 1 |
| Bhambri, S; Del Rosso, JQ; Jitpraphai, W; Momin, S | 1 |
| Calvarese, B; Chen, D; Thiboutot, D; Webster, G; Weiss, J; Zaenglein, A | 1 |
| Calvarese, B; Chen, D; Gold, MH; Mraz, S; Rich, P; Webster, G | 1 |
| Haddican, M; Patel, RV; Wong, V; Zeichner, JA | 1 |
| Alió Sáenz, AB; Hashimoto, H; Kawashima, M; Ono, M; Yamada, M | 1 |
| Cook-Bolden, FE; Korotzer, A; Pariser, DM; Rich, P | 1 |
| Del Rosso, JQ | 2 |
| Altavilla, G; Borgia, F; Cannavò, SP; Guarneri, F; Pollicino, A; Vaccaro, M | 2 |
| Stein Gold, L | 1 |
| Kircik, LH | 1 |
| Baldwin, HE; Lin, T; Stein Gold, L | 1 |
| Endo, A; Hatanaka, T; Hayashi, N; Kawashima, M; Kurokawa, I; Siakpere, O; Yamada, M | 1 |
| Baldwin, H; Beer, K; Bhatt, V; Callender, V; Draelos, Z; Gold, M; Kircik, LH; Lain, E; Pariser, DM; Pillai, R; Sadick, N; Stein Gold, L; Tanghetti, EA; Weiss, JS | 1 |
| Bhatia, N; Draelos, ZD; Kircik, LH; Stein Gold, L; Sugarman, JL; Tanghetti, EA; Zeichner, JA | 1 |
4 review(s) available for benzoyl peroxide and clindamycin phosphate
| Article | Year |
|---|---|
Clindamycin phosphate 1.2%- tretinoin 0.025% gel: vehicle characteristics, stability, and tolerability.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatitis, Irritant; Dermatologic Agents; Drug Combinations; Drug Interactions; Drug Stability; Gels; Humans; Pharmaceutical Vehicles; Skin Absorption; Tretinoin | 2008 |
Topical therapy for acne in women: is there a role for clindamycin phosphate-benzoyl peroxide gel?
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Age Factors; Anti-Bacterial Agents; Benzoyl Peroxide; Cicatrix; Clindamycin; Drug Combinations; Female; Gels; Humans; Hyperpigmentation; Randomized Controlled Trials as Topic; Treatment Outcome | 2014 |
When do efficacy outcomes in clinical trials correlate with clinical relevance? analysis of clindamycin phosphate 1.2%-benzoyl peroxide 3.75% gel in moderate to severe acne vulgaris.
Topics: Acne Vulgaris; Benzoyl Peroxide; Chronic Disease; Clindamycin; Clinical Trials as Topic; Dermatologic Agents; Humans; Patient Compliance; Treatment Outcome | 2016 |
Management of Severe Acne Vulgaris With Topical Therapy.
Topics: Acne Vulgaris; Administration, Cutaneous; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Humans; Severity of Illness Index | 2017 |
16 trial(s) available for benzoyl peroxide and clindamycin phosphate
| Article | Year |
|---|---|
[1 percent clindamycin phosphate solution versus 5 percent benzoyl peroxide gel in papulopustular acne].
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Benzoyl Peroxide; Clindamycin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Male; Peroxides; Random Allocation | 1988 |
A comparative study of benzoyl peroxide and clindamycin phosphate for treating acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Benzoyl Peroxide; Clindamycin; Clinical Trials as Topic; Female; Humans; Male; Peroxides; Random Allocation | 1988 |
Comparison of topical clindamycin phosphate, benzoyl peroxide, and a combination of the two for the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adolescent; Adult; Benzoyl Peroxide; Child; Clindamycin; Drug Therapy, Combination; Female; Humans; Male; Peroxides | 1984 |
Treatment of acne vulgaris: combination of 3% erythromycin and 5% benzoyl peroxide in a gel compared to clindamycin phosphate lotion.
Topics: Acne Vulgaris; Administration, Topical; Adult; Analysis of Variance; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Female; Humans; Keratolytic Agents; Middle Aged; Treatment Outcome | 1996 |
Skin tolerance of adapalene 0.1% gel in combination with other topical antiacne treatments.
Topics: Adapalene; Administration, Topical; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzoyl Peroxide; Clindamycin; Double-Blind Method; Erythromycin; Female; Gels; Humans; Keratolytic Agents; Male; Middle Aged; Naphthalenes; Skin | 1997 |
Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Decanoic Acids; Drug Combinations; Epidemiologic Methods; Erythromycin; Female; Humans; Male; Patient Compliance; Patient Satisfaction; Treatment Outcome; Zinc Acetate | 2006 |
An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients.
Topics: Acne Vulgaris; Adolescent; Adult; Aged; Benzoyl Peroxide; Child; Clindamycin; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Treatment Outcome | 2008 |
Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Aged; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Gels; Humans; Male; Middle Aged; Severity of Illness Index; Treatment Outcome; Young Adult | 2009 |
Clindamycin phosphate 1·2%-benzoyl peroxide 3·0% fixed-dose combination gel has an effective and acceptable safety and tolerability profile for the treatment of acne vulgaris in Japanese patients: a phase III, multicentre, randomised, single-blinded, acti
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Single-Blind Method; Treatment Outcome; Young Adult | 2015 |
An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate to severe acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Chemistry, Pharmaceutical; Child; Clindamycin; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Gels; Humans; Male; Patient Satisfaction; Severity of Illness Index; Treatment Outcome; Water; Young Adult | 2014 |
Efficacy, tolerability and impact on quality of life of clindamycin phosphate and benzoyl peroxide for the treatment of cetuximab-associated acneiform eruption in patients with metastatic colorectal cancer.
Topics: Acneiform Eruptions; Administration, Cutaneous; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Benzoyl Peroxide; Cetuximab; Clindamycin; Colorectal Neoplasms; Erythema; Follow-Up Studies; Gels; Humans; Male; Middle Aged; Pruritus; Quality of Life | 2016 |
Efficacy and Tolerability of a Fixed Combination of Clindamycin Phosphate (1.2%) and Benzoyl Peroxide (3.75%) Aqueous Gel in Moderate and Severe Acne Vulgaris Subpopulations.
Topics: Acne Vulgaris; Adolescent; Benzoyl Peroxide; Child; Clindamycin; Double-Blind Method; Drug Combinations; Female; Gels; Humans; Male; Severity of Illness Index; Treatment Outcome; Young Adult | 2015 |
Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Aqueous Gel: Long-Term Use in Adult Females With Moderate Acne Vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Adult; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Combinations; Erythema; Female; Gels; Humans; Middle Aged; Patient Satisfaction; Treatment Outcome | 2017 |
Clindamycin phosphate 1.2%/benzoyl peroxide 3% fixed-dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, invest
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Benzoyl Peroxide; Clindamycin; Combined Modality Therapy; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Japan; Male; Patient Preference; Quality of Life; Severity of Illness Index; Young Adult | 2018 |
Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Young Adult | 2022 |
Dermal sensitization, safety, and tolerability of triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel from three clinical trials.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Benzoyl Peroxide; Humans; Peroxides; Single-Blind Method | 2023 |
5 other study(ies) available for benzoyl peroxide and clindamycin phosphate
| Article | Year |
|---|---|
On therapeutic approaches to some special types of acne.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Androgen Antagonists; Anti-Inflammatory Agents; Benzoyl Peroxide; Clindamycin; Cyproterone; Cyproterone Acetate; Diazepam; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Erythromycin; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Male; Sulfamethoxazole; Tetracycline; Tretinoin; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
Clindoxyl gel for the treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Combinations; Gels; Humans | 2002 |
The clinical impact of vehicle technology using a patented formulation of benzoyl peroxide 5%/clindamycin 1% gel: comparative assessments of skin tolerability and evaluation of combination use with a topical retinoid.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Anti-Bacterial Agents; Benzoyl Peroxide; Chemistry, Pharmaceutical; Clindamycin; Drug Combinations; Evaluation Studies as Topic; Female; Gels; Humans; Multicenter Studies as Topic; Patient Satisfaction; Pharmaceutical Vehicles; Randomized Controlled Trials as Topic; Retinoids; Skin; Treatment Outcome | 2006 |
Efficacy and safety of a ceramide containing moisturizer followed by fixed-dose clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel in the morning in combination with a ceramide containing moisturizer followed by tretinoin 0.05% gel in the evening for th
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Benzoyl Peroxide; Ceramides; Clindamycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gels; Humans; Male; Treatment Outcome; Tretinoin; Young Adult | 2012 |
Efficacy of clindamycin phosphate and benzoyl peroxide gel (DUAC(®) ) in the treatment of EGFR inhibitors-associated acneiform eruption.
Topics: Acneiform Eruptions; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; ErbB Receptors; Gels; Humans; Male | 2016 |